AI screening for opioid use disorder associated with fewer hospital readmissions

An artificial intelligence (AI)-driven screening tool, developed by a National Institutes of Health (NIH)-funded research team, successfully identified hospitalized adults at risk for opioid use disorder and recommended referral to inpatient addiction specialists. The AI-based method was just as effective as a health provider-only approach in initiating addiction specialist consultations and recommending monitoring of opioid withdrawal. Compared to patients who …

Predictive Models Show Promise in Preventing Suicide

Over 40% of people who die by suicide  visit a health care provider in the month before their death, underscoring the critical role of health care settings in suicide prevention. Researchers have been trying to find better ways of quickly and accurately detecting suicide risk in these settings. One tactic that has shown promise is analyzing electronic health records (EHRs) to quickly …

NET Device

The NET DeviceTM reduces opioid withdrawal symptoms in 24 hours without the use of medication, making long-term recovery more attainable for Kentuckians Isaiah House, Kentucky’s largest community-focused nonprofit addiction treatment organization, is proud to announce its groundbreaking partnership with NET Recovery to offer NET Recovery’s proprietary neurostimulation therapy (NET®) in the Commonwealth.

Emerging Drug: Medetomidine

Animal Sedative aka Rhino Tranq Silently has become the dominant additive to Fentanyl, first appearing in May 2024. As of January 2025, more frequently detected in fentanyl than xylazine, Medetomidine is now found in 87% of Philadelphia drug samples. Medetomidine is 200 times more potent than xylazine (DEA). Major ramifications is worsening and more severe withdrawal symptoms to include intractable …

The FDA Approves “Novel Non-Opioid Treatment for Moderate to Severe Acute Pain”

Many people become addicted to opioids because they were prescribed them for pain For those who don’t already know, many people become addicted to opioids through legitimately being prescribed them. Imagine you are working in a warehouse1, and you mess up your back lifting heavy boxes, thus requiring surgery. Back surgery is extremely painful to recover from, and you’re prescribed hydrocodone (or …

Grey Death

Gray death is the name given to a new street drug that began showing up in certain regions at the end of 2016 and early 2017. It contains a blend of opioid substances (such as heroin, fentanyl, and U-47700, or “Pink”). Combinations vary between samples and are typically so strong that they can cause immediate death by overdose—not only among …

What You Need To Know About DMT

DMT is a hallucinogenic tryptamine drug that occurs naturally in various plants, such as Psychotria viridis or Chacruna. Some people call it the “spirit molecule” due to the intense psychedelic experience. Although less familiar than other psychedelics such as LSD or magic mushrooms, N,N-Dimethyltryptamine (DMT) produces a brief but intense visual and auditory hallucinogenic experience. DMT is a Schedule I …

What is pink cocaine? The party drug reportedly taken by Liam Payne

The drug cocktail that can contain ketamine, ecstasy, meth and crack has grown in popularity in recent years. What is pink cocaine?Pink cocaine is a cocktail of drugs that usually does not include cocaine. The mixture, which owes its colour to the addition of food dye and sometimes strawberry flavouring, usually contains at least one stimulant drug and one depressant. …

DEA Issues Warning About Illegal Online Pharmacies

October 4, 2024 – The U.S. Drug Enforcement Administration has seen an increase in illegal online pharmacies selling and shipping counterfeit pills made with fentanyl and methamphetamine to unsuspecting customers in the United States who believe they are purchasing real pharmaceutical drugs such as Oxycodone, Adderall, Xanax, and other drugs from legitimate pharmacies. As Americans increasingly turn to online pharmacies …

Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of inpatient services related to behavioral health (such as for mental health and substance use disorders) than adults receiving the recommended dose, according to an analysis funded by the National …